Archive USAID

Drug safety and monitoring are key as bedaquiline donation program launches in Georgia

In April 2015, USAID and Janssen Therapeutics officially launched the bedaquiline donation initiative, under which Janssen committed to providing free bedaquiline to 30,000 patients with multidrug-resistant tuberculosis (MDR-TB) over a four-year period. Bedaquiline is the first anti-TB medicine to be approved by the U.S. Food and Drug Administration in more than 40 years, and is … Read more

, , , , ,

Beating Tuberculosis Requires More Than Medicine

By Emily Delmotte, SIAPS Technical Advisor This has been cross-posted with the permission of Science Speaks. The text has been changed slightly for clarity. Eight years ago Busisiwe Beko was undergoing treatment for multidrug-resistant tuberculosis (MDR-TB) when, after months of waiting to see a pediatric specialist, her daughter was diagnosed with the same illness. The … Read more

, , , , , , , ,